Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 10/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.39 |
| ▸ | PPARG | P37231 | 6/20 | 0.39 |
| ▸ | PPARD | Q03181 | 6/20 | 0.39 |
| ▸ | PPARA | Q07869 | 6/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TLR2 | O60603 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | FABP4 | P15090 | 2/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8609138 | 1.00 | GPR84 (0.50) | GPR84CA2MAPK1AKR1B1FFAR4 | |
| SCHEMBL6461000 | 1.00 | GPR84 (0.50) | GPR84CA2MAPK1AKR1B1FFAR4 | |
| SCHEMBL4433437 | 0.93 | GPR84 (0.59) | GPR84AKR1B1FFAR4FFAR1PPARG | |
| SCHEMBL6463301 | 0.93 | GPR84 (0.59) | GPR84AKR1B1FFAR4FFAR1PPARG | |
| SCHEMBL29893958 | 0.93 | GPR84 (0.59) | GPR84AKR1B1FFAR4FFAR1PPARG | |
| SCHEMBL6466759 | 0.91 | GPR84 (0.62) | GPR84FFAR4FFAR1PPARGPPARD | |
| SCHEMBL28499460 | 0.91 | GPR84 (0.62) | GPR84FFAR4FFAR1PPARGPPARD | |
| SCHEMBL29894891 | 0.91 | GPR84 (0.62) | GPR84FFAR4FFAR1PPARGPPARD | |
| SCHEMBL6461561 | 0.91 | GPR84 (0.62) | GPR84FFAR4FFAR1PPARGPPARD | |
| SCHEMBL6465804 | 0.91 | GPR84 (0.62) | GPR84FFAR4FFAR1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116715908-A | Nitrile composite insulating sheath mobile flexible cable and production process thereof | 安徽鸿海电缆有限公司 | 2023-09-08 | — | — | CN | claimed |
| CN-110615859-A | Preparation method of sugammadex sodium | 鲁南制药集团股份有限公司 | 2019-12-27 | — | — | CN | claimed |
| CN-116715908-A | Nitrile composite insulating sheath mobile flexible cable and production process thereof | 安徽鸿海电缆有限公司 | 2023-09-08 | — | — | CN | disclosed |
| CN-101084186-B | Isocyanate compound and process for producing the same, and reactive monomer, reactive (meth)acrylate polymer and its use | SHOWA DENKO KK | 2011-05-11 | — | — | CN | disclosed |
| CN-101084186-A | Ethylenically unsaturated group-containing isocyanate compound and process for producing the same, and reactive monomer, reactive (meth)acrylate polymer and its use | SHOWA DENKO KK (JP) | 2007-12-05 | — | — | CN | disclosed |
| US-6903233-B2 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-06-07 | — | — | US | disclosed |
| US-20030225301-A1 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-12-04 | — | — | US | disclosed |
| EP-1344763-A1 | Process for producing optically active 3-halogenocarboxylic acid esters and 3-azide-carboxylic acid esters | Takasago International Corporation (JP) | 2003-09-17 | — | — | EP | disclosed |
| EP-0799830-B1 | Imidazothiazol derivatives as components of liquid crystalline mixtures | ROLIC AG (CH) | 2002-05-29 | — | — | EP | disclosed |
| US-5851425-A | Imidazothiazoles | ROLIC AG (CH) | 1998-12-22 | — | — | US | disclosed |
| EP-0799830-A1 | Imidazothiazol derivatives as components of liquid crystalline mixtures | Rolic AG (CH) | 1997-10-08 | — | — | EP | disclosed |
| EP-0269963-B1 | Ferroelectric liquid crystals | HOFFMANN LA ROCHE (CH) | 1995-02-22 | — | — | EP | disclosed |
| US-5100577-A | FERROELECTRIC LIQUID CRYSTAL MIXTURES AND COMPOUNDS AS WELL AS ELECTRO-OPTICAL DEVICES EMPLOYING SAME | HOFFMAN-LA ROCHE INC. (US) | 1992-03-31 | — | — | US | disclosed |
| EP-0269963-A2 | Ferroelectric liquid crystals | F. HOFFMANN-LA ROCHE AG (CH) | 1988-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225301-A1 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | HDHD5, APEH, AOC3 | GPR84 3209/4885CA2 18/4885MAPK1 1566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.